223 related articles for article (PubMed ID: 15915782)
1. PSA screening.
Cohen S; Schiff S; Kelty P
Med Health R I; 2005 Mar; 88(3):90-1. PubMed ID: 15915782
[No Abstract] [Full Text] [Related]
2. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
[TBL] [Abstract][Full Text] [Related]
3. PSA and prostate cancer screening: the challenge of the new millennium.
Bjartell A
Eur Urol; 2007 Nov; 52(5):1284-6. PubMed ID: 17720305
[No Abstract] [Full Text] [Related]
4. Screening for prostate cancer: the role of prostate-specific antigen.
Ferrer RL
Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171
[No Abstract] [Full Text] [Related]
5. AUA issues a policy report on PSA monitoring. The American Urological Association.
Scott Morey S
Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
[No Abstract] [Full Text] [Related]
6. [PSA based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
[No Abstract] [Full Text] [Related]
7. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
8. [The prostate specific antigen: what can we learn from the American experience?].
Zhao XJ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
[No Abstract] [Full Text] [Related]
9. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
Hayes JH; Barry MJ; Kantoff PW; Stahl JE
BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
[No Abstract] [Full Text] [Related]
10. Is the PSA test useless?
Kirby R; Moul JW
Prostate Cancer Prostatic Dis; 2004; 7(4):271-2. PubMed ID: 15592438
[No Abstract] [Full Text] [Related]
11. [About Psa-screening].
Hakama M; Auvinen A; Stenman UH; Tammela T
Duodecim; 1996; 112(14):1314-6. PubMed ID: 10596108
[No Abstract] [Full Text] [Related]
12. Point-of-care PSA testing: an evaluation of PSAwatch.
Karim O; Rao A; Emberton M; Cochrane D; Partridge M; Edwards P; Walker I; Davidson I
Prostate Cancer Prostatic Dis; 2007; 10(3):270-3. PubMed ID: 17353914
[TBL] [Abstract][Full Text] [Related]
13. PSA updated: still relevant in the new millennium?
Shah JB; Reese AC; McKiernan JM; Benson MC
Eur Urol; 2005 Apr; 47(4):427-32. PubMed ID: 15774237
[No Abstract] [Full Text] [Related]
14. PSA screening--a review of recent studies.
Schröder FH
Eur J Cancer; 2009 Sep; 45 Suppl 1():402-4. PubMed ID: 19775647
[No Abstract] [Full Text] [Related]
15. Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.
Määttänen L; Hakama M; Tammela TL; Ruutu M; Ala-Opas M; Juusela H; Martikainen P; Stenman UH; Auvinen A
Br J Cancer; 2007 Jan; 96(1):56-60. PubMed ID: 17213825
[TBL] [Abstract][Full Text] [Related]
16. Prostate specific antigen (PSA)-based screening.
Suzuki H; Flanigan RC; Okuyama A;
Int J Urol; 2008 Sep; 15(9):757-62. PubMed ID: 18786202
[No Abstract] [Full Text] [Related]
17. New Zealand should introduce population screening for prostate cancer using PSA testing: yes.
Smart R
J Prim Health Care; 2009 Dec; 1(4):319-20. PubMed ID: 20690342
[No Abstract] [Full Text] [Related]
18. Prostate specific antigen screening and active surveillance in the elderly.
Konety BR
J Urol; 2009 Apr; 181(4):1534-5. PubMed ID: 19230925
[No Abstract] [Full Text] [Related]
19. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
20. Prostate-specific antigen (PSA) should drive doing prostate biopsies.
Loeb S; Catalona WJ
Urol Oncol; 2012; 30(1):1-2. PubMed ID: 21458316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
